Concepedia

Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

Geert D’Haens, Sander van Deventer, Ruud van Hogezand, Douglas M. Chalmers, C Kothe, Filip Baert, Tanja Braakman, T Schaible, Karel Geboes, Paul Rutgeerts

Gastroenterology · 1999 · 756 citations · 23 references

DOIFull text

Open access

Concepts

References

23

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine · 1997 · 3.2K citations · Full text

, , +12

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)

Hendrik M. van Dullemen, Sander J. H. van Deventer, Daan W. Hommes et al. · Gastroenterology · 1995 · 1.1K citations

, , +9

Treatment of Crohn's Disease with 6-Mercaptopurine

Daniel H. Present, Burton I. Korelitz, Nathaniel Wisch et al. · New England Journal of Medicine · 1980 · 1K citations

, , +13

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

J Y Mary, R Modigliani · Gut · 1989 · 881 citations · Full text

, , +17

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

Geert D’Haens, Karel Geboes, Filip Baert et al. · Gastroenterology · 1998 · 867 citations · Full text

, , +14